Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma

Adam C. Seegmiller, Yin Xu, Robert W. McKenna, Nitin J. Karandikar

Research output: Contribution to journalArticlepeer-review

73 Scopus citations


Some non-Hodgkin lymphomas show marked plasmacytic differentiation. In such cases, it may be difficult to differentiate these lymphomas from plasmacytoma or myeloma, especially with limited diagnostic material. However, there may be immunophenotypic differences in the plasma cells in these disorders that distinguish them. This study characterizes the immunophenotypes of neoplastic plasma cells in 41 cases of B-lineage non-Hodgkin lymphoma and compares them with those in plasma cell myeloma. We found that plasma cells in lymphoma were significantly more likely to express CD19, CD45, and surface immunoglobulin and less likely to express CD56 than those in myeloma. We further show that CD19 and CD56 expression can be used reliably to distinguish these entities. Myeloma-associated osseous lesions and solitary plasmacytoma of bone showed myeloma-like immunophenotypes. However, some extramedullary plasmacytomas showed lymphoma-like phenotypes, suggesting that, in reality, they may represent non-Hodgkin lymphomas with extensive plasmacytic differentiation.

Original languageEnglish (US)
Pages (from-to)176-181
Number of pages6
JournalAmerican journal of clinical pathology
Issue number2
StatePublished - Feb 2007
Externally publishedYes


  • Flow cytometry
  • Non-Hodgkin lymphoma
  • Plasma cell myeloma
  • Plasma cells


Dive into the research topics of 'Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma'. Together they form a unique fingerprint.

Cite this